FR2791059B1 - Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee - Google Patents

Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee

Info

Publication number
FR2791059B1
FR2791059B1 FR9915067A FR9915067A FR2791059B1 FR 2791059 B1 FR2791059 B1 FR 2791059B1 FR 9915067 A FR9915067 A FR 9915067A FR 9915067 A FR9915067 A FR 9915067A FR 2791059 B1 FR2791059 B1 FR 2791059B1
Authority
FR
France
Prior art keywords
modified protein
compositions
preparing
same
external application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9915067A
Other languages
English (en)
Other versions
FR2791059A1 (fr
Inventor
Mu Sung Kim
Sung Gu Lee
Byung Young Kang
Dong Chul Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacific Corp
Original Assignee
Pacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Corp filed Critical Pacific Corp
Publication of FR2791059A1 publication Critical patent/FR2791059A1/fr
Application granted granted Critical
Publication of FR2791059B1 publication Critical patent/FR2791059B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF] (urogastrone)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
FR9915067A 1999-03-19 1999-11-30 Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee Expired - Lifetime FR2791059B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990009380A KR100283848B1 (ko) 1999-03-19 1999-03-19 안정화된 효소 또는 단백질을 제조하는 방법 및 이에 의해 제공되는 안정화 효소 또는 단백질을 함유하는 외용제 조성물

Publications (2)

Publication Number Publication Date
FR2791059A1 FR2791059A1 (fr) 2000-09-22
FR2791059B1 true FR2791059B1 (fr) 2005-04-01

Family

ID=19577056

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9915067A Expired - Lifetime FR2791059B1 (fr) 1999-03-19 1999-11-30 Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee

Country Status (4)

Country Link
US (1) US6406897B1 (fr)
JP (1) JP4077126B2 (fr)
KR (1) KR100283848B1 (fr)
FR (1) FR2791059B1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100338327B1 (ko) * 2000-05-16 2002-08-07 주식회사 태평양 피부 외용제 내의 활성성분의 피부 흡수를 증진시킬 수있는 조성물
KR100447055B1 (ko) * 2001-07-30 2004-09-04 주식회사 참 존 변성 알터난의 제조방법 및 이를 이용한 효소 안정화 방법
KR20030055442A (ko) * 2001-12-26 2003-07-04 주식회사 참 존 다당체를 이용한 안정화 효소의 제조방법 및 이들 안정화효소가 첨가된 조성물
KR100507960B1 (ko) * 2002-10-22 2005-08-19 (주)나노팜 피부 각질 제거용 조성물, 이의 제조방법, 및 이를 포함하는 세안조성물
KR100499564B1 (ko) * 2003-03-28 2005-07-07 신석봉 모발의 재생방법 및 발모제 조성물
US8470315B2 (en) * 2004-04-13 2013-06-25 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
WO2006016595A1 (fr) * 2004-08-10 2006-02-16 Nrl Pharma, Inc. Complexe de lactoférine et méthode pour le produire
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
KR100654063B1 (ko) * 2005-08-11 2006-12-06 주식회사 코리아나화장품 베타-１,６-분지-베타-１,３-글루칸을 포접하여 안정화한나노리포좀을 유효성분으로 함유하는 피부노화 방지용화장료 조성물
EP2044097A4 (fr) * 2006-06-23 2010-10-06 Quintessence Biosciences Inc Ribonucléases modifiées
WO2008010991A2 (fr) 2006-07-17 2008-01-24 Quintessence Biosciences, Inc. Méthodes et compositions pour le traitement du cancer
US20080160043A1 (en) * 2007-07-16 2008-07-03 Kim Moo-Sung Preparation method of beta-glucan from schizophyllum commune and composition for external application comprising the same
JP2010540681A (ja) * 2007-10-08 2010-12-24 クインテッセンス バイオサイエンシズ，インコーポレーテッド リボヌクレアーゼに基づく治療のための組成物及び方法
US8246992B2 (en) 2007-11-01 2012-08-21 Osaka City University β-1,3-glucan-derived polyaldehyde/polyamine hydrogel
US8029782B2 (en) 2008-10-01 2011-10-04 Quintessence Biosciences, Inc. Therapeutic ribonucleases
US8852750B2 (en) 2011-03-29 2014-10-07 Wintershall Holding GmbH Method for the coating of a cellulose material by using a glucan
EP2694731A1 (fr) * 2011-03-29 2014-02-12 Basf Se Procédé pour le revêtement d'une matière à base de cellulose à l'aide d'un glucane
TW201333203A (zh) * 2011-10-28 2013-08-16 Sunstar Engineering Inc 組成物及其製造方法
US10195270B2 (en) 2014-02-06 2019-02-05 Japan Science And Technology Agency Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex
KR101955230B1 (ko) * 2016-04-08 2019-03-11 주식회사 마크로케어 분리형 화장료 제형
CN110090170B (zh) * 2018-06-26 2022-06-28 浙江立恩生物科技有限公司 具有生发固发防脱的生物多糖及其应用
WO2023172070A1 (fr) * 2022-03-08 2023-09-14 주식회사 코넥스트 Composition comprenant de la collagénase, du calcium, de l'histidine et de la glycine, et procédé de stabilisation de la collagénase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556554A (en) 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
US5116612A (en) * 1987-06-23 1992-05-26 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5230891A (en) 1990-08-20 1993-07-27 Kanebo Limited Modified protease, method of producing the same and cosmetic products containing the modified protease
JP2922278B2 (ja) * 1990-10-02 1999-07-19 協和メデックス株式会社 成分分析用試薬組成物
EP0595209A3 (en) * 1992-10-23 1996-07-17 R I T A Corp An Illinois Corp Cosmetic composition
US5821343A (en) * 1996-04-25 1998-10-13 Medtronic Inc Oxidative method for attachment of biomolecules to surfaces of medical devices

Also Published As

Publication number Publication date
US6406897B1 (en) 2002-06-18
JP4077126B2 (ja) 2008-04-16
KR100283848B1 (ko) 2001-02-15
FR2791059A1 (fr) 2000-09-22
KR20000060771A (ko) 2000-10-16
JP2000273182A (ja) 2000-10-03

Similar Documents

Publication Publication Date Title
FR2791059B1 (fr) Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
HUP0103567A3 (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same
EP1129683A4 (fr) Gel d'acide hyaluronique son procede de preparation et produit medical le contenant
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO20010475D0 (no) Fremgangsmåte til fremstilling av antimikrobielle artikler
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
EE04739B1 (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
IL137494A0 (en) Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
FR2833259B1 (fr) Procede de preparation de 2-arylbenzofuranes, composes intermediaires, 2-arylbenzofuranes et compositions les comprenant
MA26609A1 (fr) Derives de retiferol, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
EE04902B1 (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
NO20005000D0 (no) FremgangsmÕte for fremstilling av rÕstoffer for glassfremstilling

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20